References
- Kish J, Drelichman A, Jacobs. Clinical trial of cisplatinum and 5-fluorouracil as initial treatment for advanced squamous carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471–4
- Jacobs J R, Pajak T F, Kinzie J. Induction chemotherapy in advanced head and neck cancer. Arch Otolaryngol 1987; 113: 193–7
- Heidelberger C. Pyrimidine and pyrimidine nucleoside antimetabolities. Cancer medicine, JF Holland, E Frei, III. Lea & Febiger, Philadelphia 1973; 768–91
- Ullman B, Martin L, Santi DV. Cytotoxicity of 5-fluoro-2′deoxyuridine; Requirement for reduced folate co-factors and antagonism by methotrexate. Proc Natl Acad Sci USA 1978; 75: 980–3
- Madajewics S, Petrelli N, Rustum YM. Phase I–II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 1984; 44: 4667–89
- Kohno N, Ohnuma T, Biller H F, Holland JF. Effects of cisplatin plus fiuorouracil vs cisplatin plus cytarabine on head and neck squamous multicellular tumor spheroids. Arch Otolaryngol 1988; 114: 157–61
- Kohno N, Ohnuma T, Holland J F, Biller HF. Effect of anticancer agents on the shedding of cells from human multicellular tumor spheroids. Invasion Metastasis 1987; 7: 264–74
- Yuhas J M, Li A P, Martinez A D, Ladman AJ. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 1977; 37: 3639–43
- Yuhas J M, Tarleton A E, Molzen KB. Multicellular tumor spheroid formation by breast cancer cells isolated from different sites. Cancer Res 1978; 38: 2486–91
- Alberts D S, Chen H-SG. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Cloning of human tumor stem cells, SE Salomon. Alan R. Liss, New York 1980; 351–9
- Kuroki T. Colony formation of mammalian cells of agar plates and its application to Lederberg's replica plating. Exp Cell Res 1974; 80: 55–62
- Chou T C, Talalay P. Quantitative analysis of dose-effect relationships; The combined effects of multiple drug or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27–55
- Chou TC. New computerized quantitative approach to combination therapy. Proc Am Assoc Cancer Res 1985; 26: 341
- Kohno N, Ohnuma T, Kaneko M, Holland JF. Interactions of doxorubicin and cisplatin in squamous carcinoma cells in culture. Br J Cancer 1988; 58: 330–4
- Thomlinson R H, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539–49
- Giesbrecht J L, Wilson W R, Hill RP. Radiobiological studies of cells in multicellular spheroids using a sequential trypsinization technique. Radiat Res 1981; 86: 368–86
- Santi D V, McHenry C S, Sommer H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974; 13: 417–81
- Sartorelli A C, Creasey WA. Combination chemotherapy. Cancer medicine, JF Holland, E Frei, III. Lea and Febiger, Philadelphia 1982; 720
- Erlichman C, Vidgen D. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids and xenografts in immune-deprived mice. Cancer Res 1984; 44: 5369
- Kerr D J, Wheldon T E, Kerr A M, Freshney R I, Kaye SB. The effect of adriamycin and 4′-deoxydoxoru-bicin on cell survival of human lung tumor cells grown in monolayer and as spheroids. Br J Cancer 1986; 54: 423–9
- Scanlon K J, Kashani-Sabet M. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma. Proc Natl Acad Sci USA 1988; 85: 650–3